0 NASDAQ Companies - July 28, 2020Sify reports Revenues of INR 5259 Million for First Quarter of FY 2020-21EBITDA for the Quarter stood at INR 1153 MillionSANTA CLARA, Calif., July 28, 2020 (GLOBE NEWSWIRE) —A photo accompanying this […]Read More
0 NASDAQ Companies - July 28, 2020VIBES Fine Rolling Papers Introduces The Highly Anticipated Cubano Cone Alongside New Streetwear CollectionBOCA RATON, Fla., July 28, 2020 (GLOBE NEWSWIRE) — Greenlane Holdings, Inc. (“Greenlane” or “the Company”) (Nasdaq: GNLN), one of […]Read More
0 NASDAQ Companies - July 28, 2020Strongbridge Biopharma plc to Host Second Quarter 2020 Financial Results Conference Call on August 4, 2020DUBLIN, Ireland and TREVOSE, Pa., July 28, 2020 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical […]Read More
0 NASDAQ Companies - July 28, 2020francesca’s® Provides Business Update and Second Quarter Outlook; Reports Final First Quarter Fiscal Year 2020 Financial ResultsHOUSTON, July 28, 2020 (GLOBE NEWSWIRE) — Francesca’s Holdings Corporation (Nasdaq: FRAN) today provides a business update and reports financial […]Read More
0 NASDAQ Companies - July 28, 2020DraftKings becomes PGA TOUR’s first Official Betting OperatorPONTE VEDRA BEACH, Fla. and BOSTON, July 28, 2020 (GLOBE NEWSWIRE) — The PGA TOUR and DraftKings Inc. (Nasdaq: DKNG), […]Read More
0 NASDAQ Companies - July 28, 2020Ivy Brain Tumor Center and BridgeBio Pharma’s QED Therapeutics Announce Dosing of First Patient in Investigator-Initiated Phase 0/2 Clinical Trial of Infigratinib in Recurrent GlioblastomaPrecision medicine study designed to confirm drug’s ability to cross blood-brain barrier and hit molecular targets in high-grade glioma patients […]Read More
0 NASDAQ Companies - July 28, 2020Momenta Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Nipocalimab in HDFNCAMBRIDGE, Mass., July 28, 2020 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) today announced that its novel drug candidate, […]Read More
0 NASDAQ Companies - July 28, 2020Myriad Announces the Launch of a New Radiographic Progression Prognostic Tool, Adding to Clinical Value of Vectra®SALT LAKE CITY, July 28, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and […]Read More
0 NASDAQ Companies - July 28, 2020Sol-Gel Technologies Partnered Generic Product Expected to Launch in the Second Quarter of 2021NESS ZIONA, Israel, July 28, 2020 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on […]Read More
0 NASDAQ Companies - July 28, 2020Cowen Announces Record Financial Results for Second Quarter 2020Reports Record 2Q20 US GAAP Net Income of $112.1 million or $3.83 per shareRecord Economic Operating Income of $166.9 million, […]Read More